Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q4 FY26ended Jun 30, 2026 | Aug 11, 2026 | $1.69 | +69.0% | $63.67B | +5.8% | $2.42 |
| Q3 FY26ended Mar 31, 2026 | May 7, 2026 | $1.69 | −19.5% | $60.94B | +11.0% | $2.80 |
| Q2 FY26ended Dec 31, 2025 | — | $1.97 | +19.4% | $65.63B | +18.8% | — |
| Q1 FY26ended Sep 30, 2025 | — | $1.88 | +10.6% | $64.01B | +22.4% | — |
| Q4 FY25ended Jun 30, 2025 | — | $1.00 | +5.3% | $60.16B | +0.5% | — |
| Q3 FY25ended Mar 31, 2025 | — | $2.10 | +96.3% | $54.88B | +0.0% | — |
| Q2 FY25ended Dec 31, 2024 | — | $1.65 | +10.0% | $55.26B | −3.8% | — |
| Q1 FY25ended Sep 30, 2024 | — | $1.70 | — | $52.28B | −4.3% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Cardinal Health shares, not any token. As of Aug 11, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q4 FY24ended Jun 30, 2024 | — | $0.95 | — | $59.87B | — | — |
| Q3 FY24ended Mar 31, 2024 | — | $1.07 | — | $54.87B | — | — |
| Q2 FY24ended Dec 31, 2023 | — | $1.50 | — | $57.44B | — | — |
| Q1 FY24ended Sep 30, 2023 | — | −$0.05 | — | $54.65B | — | — |